A High Cell Density Fermentation Strategy to Produce Recombinant Malarial Antigen in E. Coli
Overview
Biotechnology
Affiliations
A high cell density cultivation method was developed to produce recombinant PvRII, a malaria vaccine candidate, in E. coli for use in vaccine studies. Cells were grown in completely defined media and glucose was fed to achieve a specific growth rate of 0.12 h(-1) until cells reached 55 g dry wt l(-1). Culture was then induced with 1 mM: IPTG and cells were further grown for 4 h to reach 85 g dry wt l(-1) at 0.1 h(-1). Recombinant PvRII was purified from inclusion bodies under denaturing conditions using metal affinity chromatography which yielded 10 mg PvRII g(-1) dry wt. After refolding, PvRII was greater than 98% pure, homogeneous and functionally active in that it specifically bound Duffy positive human red cells.
Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.
Ntumngia F, Barnes S, McHenry A, George M, Schloegel J, Adams J Clin Vaccine Immunol. 2014; 21(9):1215-23.
PMID: 24964808 PMC: 4178564. DOI: 10.1128/CVI.00205-14.
Ntumngia F, Schloegel J, McHenry A, Barnes S, George M, Kennedy S Vaccine. 2013; 31(40):4382-8.
PMID: 23916294 PMC: 4497540. DOI: 10.1016/j.vaccine.2013.07.002.
Ntumngia F, Schloegel J, Barnes S, McHenry A, Singh S, King C Infect Immun. 2012; 80(3):1203-8.
PMID: 22215740 PMC: 3294652. DOI: 10.1128/IAI.05924-11.
Ntumngia F, Adams J Clin Vaccine Immunol. 2011; 19(1):30-6.
PMID: 22116684 PMC: 3255949. DOI: 10.1128/CVI.05466-11.
Moreno A, Caro-Aguilar I, Yazdani S, Shakri A, Lapp S, Strobert E Vaccine. 2008; 26(34):4338-44.
PMID: 18573299 PMC: 2532489. DOI: 10.1016/j.vaccine.2008.06.010.